Capital Research Global Investors
Institutional investor · Portfolio as of Q4 2022
Top Holdings436 positions
Microsoft Corp. | 78.1M | $18.7B | 5.7% | $102.28 | +127.56% | 17 qtrssince 2018-Q4 | Decreased 0 |
Broadcom Inc | 21.8M | $12.2B | 3.7% | $23.94 | +122.09% | 17 qtrssince 2018-Q4 | Increased 60 |
UnitedHealth Group Inc. | 17.3M | $9.2B | 2.8% | $246.38 | +99.76% | 17 qtrssince 2018-Q4 | Decreased 0 |
GE Aerospace | 102.1M | $8.6B | 2.6% | $55.76 | -8.18% | 6 qtrssince 2021-Q3 | Increased 61 |
Abbott Laboratories | 76.8M | $8.4B | 2.5% | $63.03 | +61.32% | 17 qtrssince 2018-Q4 | Decreased 0 |
RAYTHEON TECHNOLOGIES CORP | 80.7M | $8.1B | 2.5% | $65.94 | +41.52% | 12 qtrssince 2020-Q1 | Increased 57 |
Amazon.com, Inc. | 87.6M | $7.4B | 2.2% | $103.19 | -18.60% | 17 qtrssince 2018-Q4 | Decreased 0 |
AbbVie Inc. | 36.7M | $5.9B | 1.8% | $97.46 | +45.14% | 17 qtrssince 2018-Q4 | Increased 51 |
Philip Morris International Inc. | 55M | $5.6B | 1.7% | $53.69 | +60.04% | 17 qtrssince 2018-Q4 | Decreased 0 |
Netflix, Inc. | 18.5M | $5.5B | 1.7% | $28.72 | +2.67% | 17 qtrssince 2018-Q4 | Increased 60 |
CANADIAN NAT RES LTD | 96.8M | $5.4B | 1.6% | $9.64 | +148.31% | 17 qtrssince 2018-Q4 | Increased 57 |
MasterCard Incorporated | 13.8M | $4.8B | 1.5% | $230.51 | +47.50% | 17 qtrssince 2018-Q4 | Increased 54 |
GILEAD SCIENCES INC | 54.6M | $4.7B | 1.4% | $51.90 | +46.22% | 17 qtrssince 2018-Q4 | Increased 51 |
COMCAST CORP NEW | 121.2M | $4.2B | 1.3% | $33.71 | -16.15% | 17 qtrssince 2018-Q4 | Increased 53 |
Thermo Fisher Scientific Inc | 7.2M | $3.9B | 1.2% | $243.83 | +123.23% | 17 qtrssince 2018-Q4 | Decreased 0 |
| 11.9M | $3.9B | 1.2% | $162.29 | +198.06% | 17 qtrssince 2018-Q4 | Increased 50 | |
Meta Platforms Inc | 31.8M | $3.8B | 1.2% | $144.75 | -17.65% | 17 qtrssince 2018-Q4 | Increased 53 |
Apple Inc. | 26.6M | $3.5B | 1.0% | $106.23 | +20.17% | 17 qtrssince 2018-Q4 | Decreased 0 |
Stryker Corporation | 14.1M | $3.4B | 1.0% | $179.31 | +31.32% | 17 qtrssince 2018-Q4 | Increased 56 |
Baker Hughes Company | 116.4M | $3.4B | 1.0% | $19.55 | +39.23% | 17 qtrssince 2018-Q4 | Decreased 0 |
Capital Research Global Investors manages $330.9B across 436 positions as of Q4 2022. Top holdings: MSFT (5.7%), AVGO (3.7%), UNH (2.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.
Active quarter - 38 new positions, 31 exits, 179 increased. Top move: GE (INCREASED, conviction 61). Portfolio: $330.9B across 436 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR